Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
SDHD
REST API REST API
Homo sapiens
SDHD is differentially expressed in 247 experiments: 106 organism parts: liver, cerebellum, ... (104 more);, 148 disease states: normal, acute myeloid leukemia, ... (146 more);, 56 cell types 302 cell lines 31 compound treatments and 66 other conditions.
Synonyms PGL1, PGL
Orthologs sdhda (Danio rerio)   SDHD (Gallus gallus)   Sdhd (Mus musculus)   sdhdb (Danio rerio)   SDHD (Bos taurus)   Sdhd (Rattus norvegicus)   CG10219 (Drosophila melanogaster)   sdhd (Xenopus laevis)   SDHD (Canis familiaris)   (Compare orthologs)
Gene Ontology Term transport, iron ion binding, mitochondrial inner membrane, membrane, respiratory electron transport chain, metal ion binding, heme binding, mitochondrial envelope, succinate dehydrogenase activity, mitochondrial respiratory chain complex II, electron carrier activity, ubiquinone binding, integral to membrane, tricarboxylic acid cycle, mitochondrion
InterPro Term Cyt_b_succ_DH_CybS
Gene-Disease Assocation PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA, PHEOCHROMOCYTOMA, COWDEN-LIKE SYNDROME, CARCINOID TUMORS, INTESTINAL, PARAGANGLIOMAS 1; PGL1
UniProt Accession O14521, E9PQI9, E9PIC0, E9PIG3, E9PK73
Search EB-eye ENSG00000204370
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-GEOD-803, E-GEOD-6573, E-GEOD-7540, E-GEOD-3526, ... (25 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-MEXP-1006, E-GEOD-19639, ... (32 experiments)

Factor Value U/D Experiments
MCF-7
2
E-GEOD-20081, E-GEOD-5823
T84
2
E-MTAB-37, E-GEOD-1474
MDA-MB-231
1
2
E-TABM-420, E-MTAB-62, E-GEOD-5823
BT20
1
E-MTAB-37
5637
1
E-MTAB-37
H15
1
E-GEOD-1309
296 more value(s).


Cell type

studied in E-GEOD-22373, E-GEOD-3920, E-GEOD-360, E-GEOD-20677, E-GEOD-13987, ... (33 experiments)

Factor Value U/D Experiments
stromal cell
2
E-GEOD-10797, E-GEOD-1460
macrophage
1
2
E-GEOD-3982, E-GEOD-360, E-GEOD-22373
CXCR4 negative
1
E-GEOD-15893
adult native RPE from 76 y.o. donor
1
E-GEOD-18811
CD4+ T cell
1
E-MTAB-24
n/a
1
E-MTAB-24
50 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-2466, E-GEOD-22148, E-GEOD-9692, ... (48 experiments)

Factor Value U/D Experiments
septic shock
2
E-GEOD-9692, E-GEOD-8121
colon carcinoma
2
E-MTAB-37, E-GEOD-3726
multiple myeloma
2
E-MTAB-62, E-GEOD-6691
meningitis infected
1
E-MTAB-62
smoldering myeloma
1
E-MTAB-62
acute myelomonocytic leukemia
1
E-MTAB-62
142 more value(s).


Compound treatment

studied in E-GEOD-6907, E-GEOD-15205, E-GEOD-5824, E-TABM-868, E-GEOD-5099, ... (20 experiments)

Factor Value U/D Experiments
lipopolysaccharide
2
E-MEXP-1958, E-TABM-868
none
3
4
E-GEOD-5824, E-GEOD-412, E-MEXP-1958, E-GEOD-2803, E-TABM-868, ... (7 experiments)
ethanol
1
E-MEXP-2241
bacterial endotoxin
1
E-GEOD-3284
unknown
1
E-GEOD-7307
heregulin
1
E-GEOD-6462
25 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


Biosource provider
studied in E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-22097, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-MEXP-1251, E-GEOD-21589, ... (6 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-MEXP-2359, E-GEOD-2666, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-GEOD-22148, E-TABM-147, E-GEOD-21138, ... (7 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-21589, E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-GEOD-4025, E-MEXP-1482, E-GEOD-7578, E-GEOD-20847 ... (5 experiments)

Genotype
studied in E-TABM-1029, E-GEOD-22056, E-GEOD-2466, E-GEOD-17476, E-GEOD-2292, ... (8 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1220, E-TABM-127, E-MEXP-1446, E-GEOD-19018, ... (7 experiments)

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

Individual
studied in E-TABM-325, E-MTAB-197, E-GEOD-2466, E-MEXP-2069, E-GEOD-1926, ... (34 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-12108, E-GEOD-12254, E-MEXP-561, E-GEOD-17400 ... (5 experiments)

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Labeling
studied in E-LGCL-5

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-GEOD-1801, E-AFMX-1, E-GEOD-426, E-TABM-84 ... (5 experiments)

Original diagnosis
studied in E-GEOD-21521

Phenotype
studied in E-GEOD-21750, E-GEOD-1657, E-MEXP-1403

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19246, E-GEOD-1343 ... (5 experiments)

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-10896

Rna integrity
studied in E-TABM-325

RNAi
studied in E-GEOD-12438, E-GEOD-1676, E-MEXP-101, E-MEXP-1857

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-18995

Sex
studied in E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-MEXP-1996

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-22369, E-GEOD-22368, E-GEOD-16837, E-GEOD-19246, E-GEOD-13818, ... (7 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor size
studied in E-GEOD-6532

Vehicle
studied in E-GEOD-5258

Processing time: 0.439 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM